Taiwan FDA registration 145fc153a9356d4267d75155a933119b

"Siemens" complement C4 test reagent

TW: “西門子” 補體C4檢驗試劑

Taiwan·Risk Class 2·RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.·Registered Jan 09, 2019 – Jan 09, 2029Active

Registration details

Analysis ID: 145fc153a9356d4267d75155a933119b
Customs Code: DHA05603202102

Company information

Manufacturer: RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.
Manufacturer Country: United Kingdom;;United States
Authorized Representative: SIEMENS HEALTHCARE LIMITED

Product details

Intended Use: This product is used with Atellica CH Analyzer to quantitatively detect complement C4 in human serum.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.5240 補體成份免疫試驗系統
Import Information: Contract manufacturing;; input

Dates and status

Registration Date: Jan 09, 2019
Expiry Date: Jan 09, 2029

About this record

Access comprehensive regulatory information for "Siemens" complement C4 test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 145fc153a9356d4267d75155a933119b and manufactured by RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.